| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT06626919 | A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases | RECRUITING | PHASE1 | 2025-04-30 | 2028-04 | 2027-03 |
| NCT05457010 | Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS | RECRUITING | PHASE1 | 2022-11-28 | 2025-11-17 | 2025-09-30 |